
Revolutionising Therapies for Neurological Diseases
Healthy Ageing and Growing-up Healthy
SMDG is developing safe, innovative, disease-modifying and life-saving therapies for some of the most debilitating diseases our societies face today. SMDG's team has focused on neurodegenerative diseases and pediatric neurological disorders as the first diseases to tackle. We do this by utilizing our ground breaking and transformative platforms for targeted and safe delivery of therapies and genetic medicines and broad understanding of these diseases for designing first in-class therapeutics.















Inspired by Nature
Designed to Heal
We are making
Tomorrow's Medicines
Precision Targeting and Receptor Mediated
We were inspired by nature to design and develop therapies for most debilitating diseases with no known or limited therapies.
We are a team of internationally renowned scientists who have been recognised globally for our work in drug delivery and research. We are innovators and entrepreneurs with extensive experience in studying nature of different diseases and designing innovative therapeutics utilising the latest technologies.
We have embarked on an ambitious path of designing better disease-modifying and First-in-Class therapies that could be safe for patients and are good for the environment.
News & Events

Pioneering Research
Our chief scientist and inventor of our Peptide Therapeutic Platforms:
Professor Moein Moghimi's laboratory has been at the forefront of pioneering and innovative research in nanomedicine, drug delivery, and biomedical engineering. His team's groundbreaking work has led to the development of advanced nanoscale technologies for targeted drug delivery, immune modulation, and diagnostic applications. By exploring novel approaches to nanocarrier design, biocompatibility, and cellular interactions, Professor Moghimi’s research has significantly influenced the fields of nanopharmacology and precision medicine. His lab's discoveries continue to pave the way for safer and more effective therapeutic strategies, ultimately transforming patient care and advancing modern medicine.
SMDG is an award-winning biotechnology company, recognised for its groundbreaking therapeutic platforms. Join us on our mission to transform the lives of patients suffering from neurological diseases and other debilitating diseases. Together, we can make a difference.

Dr Farhangrazi recognised as a 2024 CEO of the year leading a life sciences company by the SME News

Healthy Tomorrow: Join Us on the Journey
Sign up to Receive News and Information
Follow us on Social Media
